ACRO BIOMEDICAL CO., LTD. Annual Operating Income (Loss) in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Acro Biomedical Co., Ltd. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2022.
  • Acro Biomedical Co., Ltd. Operating Income (Loss) for the quarter ending June 30, 2023 was -$3.19M, a 20.1% increase year-over-year.
  • Acro Biomedical Co., Ltd. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$15.1M, a 2.54% decline year-over-year.
  • Acro Biomedical Co., Ltd. annual Operating Income (Loss) for 2022 was -$15.9M, a 106% decline from 2021.
  • Acro Biomedical Co., Ltd. annual Operating Income (Loss) for 2021 was -$7.69M, a 5797% decline from 2020.
  • Acro Biomedical Co., Ltd. annual Operating Income (Loss) for 2020 was -$130K, a 69.1% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$15.9M -$8.18M -106% Jan 1, 2022 Dec 31, 2022 10-K 2023-07-21
2021 -$7.69M -$7.56M -5797% Jan 1, 2021 Dec 31, 2021 10-K 2023-07-21
2020 -$130K +$292K +69.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 -$423K -$938K -182% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-02
2018 $516K +$518K Oct 1, 2017 Sep 30, 2018 10-KT 2020-03-27
2017 -$2.25K -$45.7K -105% Oct 1, 2016 Sep 30, 2017 10-K 2018-12-28
2016 $43.4K Oct 1, 2015 Sep 30, 2016 10-K 2016-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.